On March 5, 2024, the Vaccines and Related Biological Products Advisory Committee will meet in open session to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccines for the 2024 to 2025 influenza season.
Back to All Events
Earlier Event: March 5
Medical Imaging Drugs Advisory Committee
Later Event: March 14
Oncology Drug Advisory Committee